Intel genx corp. – product pipeline review – 2012


Published on

2012 | | Intel genx corp. – product pipeline review – 2012

Published in: Business
  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Intel genx corp. – product pipeline review – 2012

  1. 1. announces, The Latest market research report is available inits vast collection:IntelGenx Corp. – Product Pipeline Review – 2012 You can also request for sample page of above mention reports onsample@aarkstore.comSummaryGlobal Markets Direct’s pharmaceuticals report, “IntelGenx Corp. - Product PipelineReview - 2012” provides data on the IntelGenx Corp.’s research and developmentfocus. The report includes information on current developmental pipeline, completewith latest updates, and features on discontinued and dormant projects.This report is built using data and information sourced from Global Markets Direct’sproprietary databases, IntelGenx Corp.’s corporate website, SEC filings, investorpresentations and featured press releases, both from IntelGenx Corp. and industry-specific third party sources, put together by Global Markets Direct’s team.Scope- IntelGenx Corp. - Brief IntelGenx Corp. overview including business description,key information and facts, and its locations and subsidiaries.- Review of current pipeline of IntelGenx Corp. human therapeutic division.- Overview of pipeline therapeutics across various therapy areas.Reasons to buy- Evaluate IntelGenx Corp.’s strategic position with total access to detailedinformation on its product pipeline.- Assess the growth potential of IntelGenx Corp. in its therapy areas of focus.- Identify new drug targets and therapeutic classes in the IntelGenx Corp.’s R&D
  2. 2. portfolio and develop key strategic initiatives to reinforce pipeline in those areas.Table of contents:List of Tables 4List of Figures 5IntelGenx Corp. Snapshot 6IntelGenx Corp. Overview 6Key Information 6Key Facts 6IntelGenx Corp. – Research and Development Overview 7Key Therapeutic Areas 7IntelGenx Corp. – Pipeline Review 9Pipeline Products by Stage of Development 9Pipeline Products – Monotherapy 10IntelGenx Corp. – Pipeline Products Glance 11IntelGenx Corp. Clinical Stage Pipeline Products 11Phase II Products/Combination Treatment Modalities 11Phase I Products/Combination Treatment Modalities 12IntelGenx Corp. – Early Stage Pipeline Products 13Pre-Clinical Products/Combination Treatment Modalities 13IntelGenx Corp. – Drug Profiles 14INT-0007 14Product Description 14Mechanism of Action 14R&D Progress 14INT-0008 15Product Description 15Mechanism of Action 15R&D Progress 15INT-0020 16Product Description 16Mechanism of Action 16R&D Progress 16INT-0022 17Product Description 17
  3. 3. Mechanism of Action 17R&D Progress 17List of FiguresList of Tables are also include.For more related Reports Plz follow The link:Product Pipeline Review – 2012 PipelineReview – 2012&PubId=&pagenum=1HanAll Biopharma Co., Ltd. – Product Pipeline Review – 2012Idenix Pharmaceuticals, Inc. – Product Pipeline Review – 2012Idenix Pharmaceuticals, Inc. – Product Pipeline Review – 2012IntelGenx Corp. – Product Pipeline Review – 2012Isis Pharmaceuticals, Inc. – Product Pipeline Review – 2012JADO Technologies GmbH – Product Pipeline Review – 2012Ligand Pharmaceuticals, Inc. – Product Pipeline Review – 2012NeuroSearch A/S – Product Pipeline Review – 2012NovaDel Pharma, Inc. – Product Pipeline Review – 2012
  4. 4. Portola Pharmaceuticals, Inc. – Product Pipeline Review – 2012Search More Reports Related to This Category :Pharmaceuticals and Healthcare andHealthcare&PubId=&pagenum=1For More details Plz do contact :Aarkstore EnterpriseLavanyaPhone:08149852585Email: